B型肝炎ワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Hepatitis B Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16412 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

B型肝炎ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のB型肝炎ワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のB型肝炎ワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 B型肝炎ワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・酵母由来、CHO由来 用途別セグメントは次のように区分されます。 ・子供用、大人用 世界のB型肝炎ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、B型肝炎ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なB型肝炎ワクチンメーカーの企業概要、2019年～2021年までのB型肝炎ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なB型肝炎ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別B型肝炎ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのB型肝炎ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのB型肝炎ワクチン市場予測を収録しています。 ・第12、13、14章では、B型肝炎ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：酵母由来、CHO由来 ・用途別分析2016年-2026年：子供用、大人用 ・B型肝炎ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・B型肝炎ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・B型肝炎ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・B型肝炎ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・B型肝炎ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hepatitis B Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hepatitis B Vaccines size is estimated to be XX million in 2021 from USD 1034 million in 2020, with a change of XX% between 2020 and 2021. The global Hepatitis B Vaccines market size is expected to grow at a CAGR of 1.7% for the next five years.

Market segmentation
Hepatitis B Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Yeast Derived
CHO Derived

Market segment by Application can be divided into
Children
Adult

The key market players for global Hepatitis B Vaccines market are listed below:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hepatitis B Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis B Vaccines, with price, sales, revenue and global market share of Hepatitis B Vaccines from 2019 to 2021.
Chapter 3, the Hepatitis B Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis B Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hepatitis B Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hepatitis B Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Hepatitis B Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepatitis B Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepatitis B Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccines Market Size & Forecast
1.4.1 Global Hepatitis B Vaccines Sales in Value (2016-2026))
1.4.2 Global Hepatitis B Vaccines Sales in Volume (2016-2026)
1.4.3 Global Hepatitis B Vaccines Price by Type (2016-2026) & (USD/Doses)
1.5 Global Hepatitis B Vaccines Production Capacity Analysis
1.5.1 Global Hepatitis B Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Hepatitis B Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis B Vaccines Market Drivers
1.6.2 Hepatitis B Vaccines Market Restraints
1.6.3 Hepatitis B Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Hepatitis B Vaccines Product and Services
2.1.4 GSK Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 NCPC
2.2.1 NCPC Details
2.2.2 NCPC Major Business
2.2.3 NCPC Hepatitis B Vaccines Product and Services
2.2.4 NCPC Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Hepatitis B Vaccines Product and Services
2.3.4 Merck Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bio Kangtai
2.4.1 Bio Kangtai Details
2.4.2 Bio Kangtai Major Business
2.4.3 Bio Kangtai Hepatitis B Vaccines Product and Services
2.4.4 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Dynavax
2.5.1 Dynavax Details
2.5.2 Dynavax Major Business
2.5.3 Dynavax Hepatitis B Vaccines Product and Services
2.5.4 Dynavax Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Hissen
2.6.1 Hissen Details
2.6.2 Hissen Major Business
2.6.3 Hissen Hepatitis B Vaccines Product and Services
2.6.4 Hissen Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Hepatitis B Vaccines Product and Services
2.7.4 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 LG Life Sciences
2.8.1 LG Life Sciences Details
2.8.2 LG Life Sciences Major Business
2.8.3 LG Life Sciences Hepatitis B Vaccines Product and Services
2.8.4 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Serum Institute
2.9.1 Serum Institute Details
2.9.2 Serum Institute Major Business
2.9.3 Serum Institute Hepatitis B Vaccines Product and Services
2.9.4 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Hepatitis B Vaccines Sales by Manufacturer
3.1 Global Hepatitis B Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hepatitis B Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hepatitis B Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Hepatitis B Vaccines Manufacturer Market Share
3.4.2 Top 6 Hepatitis B Vaccines Manufacturer Market Share
3.5 Global Hepatitis B Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hepatitis B Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hepatitis B Vaccines Market Size by Region
4.1.1 Global Hepatitis B Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Hepatitis B Vaccines Revenue by Region (2016-2026)
4.2 North America Hepatitis B Vaccines Revenue (2016-2026)
4.3 Europe Hepatitis B Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Hepatitis B Vaccines Revenue (2016-2026)
4.5 South America Hepatitis B Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Hepatitis B Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hepatitis B Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Hepatitis B Vaccines Revenue by Type (2016-2026)
5.3 Global Hepatitis B Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hepatitis B Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Hepatitis B Vaccines Revenue by Application (2016-2026)
6.3 Global Hepatitis B Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hepatitis B Vaccines Sales by Type (2016-2026)
7.2 North America Hepatitis B Vaccines Sales by Application (2016-2026)
7.3 North America Hepatitis B Vaccines Market Size by Country
7.3.1 North America Hepatitis B Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Hepatitis B Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hepatitis B Vaccines Sales by Type (2016-2026)
8.2 Europe Hepatitis B Vaccines Sales by Application (2016-2026)
8.3 Europe Hepatitis B Vaccines Market Size by Country
8.3.1 Europe Hepatitis B Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Hepatitis B Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hepatitis B Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Hepatitis B Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Hepatitis B Vaccines Market Size by Region
9.3.1 Asia-Pacific Hepatitis B Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hepatitis B Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hepatitis B Vaccines Sales by Type (2016-2026)
10.2 South America Hepatitis B Vaccines Sales by Application (2016-2026)
10.3 South America Hepatitis B Vaccines Market Size by Country
10.3.1 South America Hepatitis B Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Hepatitis B Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hepatitis B Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Hepatitis B Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Hepatitis B Vaccines Market Size by Country
11.3.1 Middle East & Africa Hepatitis B Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hepatitis B Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hepatitis B Vaccines Typical Distributors
12.3 Hepatitis B Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Hepatitis B Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hepatitis B Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Hepatitis B Vaccines Product and Services
Table 6. GSK Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. NCPC Basic Information, Manufacturing Base and Competitors
Table 8. NCPC Major Business
Table 9. NCPC Hepatitis B Vaccines Product and Services
Table 10. NCPC Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Hepatitis B Vaccines Product and Services
Table 14. Merck Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 16. Bio Kangtai Major Business
Table 17. Bio Kangtai Hepatitis B Vaccines Product and Services
Table 18. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dynavax Basic Information, Manufacturing Base and Competitors
Table 20. Dynavax Major Business
Table 21. Dynavax Hepatitis B Vaccines Product and Services
Table 22. Dynavax Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Hissen Basic Information, Manufacturing Base and Competitors
Table 24. Hissen Major Business
Table 25. Hissen Hepatitis B Vaccines Product and Services
Table 26. Hissen Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 28. KM Biologics Major Business
Table 29. KM Biologics Hepatitis B Vaccines Product and Services
Table 30. KM Biologics Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. LG Life Sciences Major Business
Table 33. LG Life Sciences Hepatitis B Vaccines Product and Services
Table 34. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 36. Serum Institute Major Business
Table 37. Serum Institute Hepatitis B Vaccines Product and Services
Table 38. Serum Institute Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Hepatitis B Vaccines Sales by Manufacturer (2019-2021e) & (M Doses)
Table 40. Global Hepatitis B Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Hepatitis B Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Hepatitis B Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021
Table 43. Head Office and Hepatitis B Vaccines Production Site of Key Manufacturer
Table 44. Hepatitis B Vaccines New Entrant and Capacity Expansion Plans
Table 45. Hepatitis B Vaccines Mergers & Acquisitions in the Past Five Years
Table 46. Global Hepatitis B Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 47. Global Hepatitis B Vaccines Sales by Region (2021-2026) & (M Doses)
Table 48. Global Hepatitis B Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Hepatitis B Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 51. Global Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 52. Global Hepatitis B Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Hepatitis B Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Hepatitis B Vaccines Price by Type (2016-2021e) & (USD/Doses)
Table 55. Global Hepatitis B Vaccines Price by Type (2021-2026) & (USD/Doses)
Table 56. Global Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 57. Global Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 58. Global Hepatitis B Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Hepatitis B Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Hepatitis B Vaccines Price by Application (2016-2021e) & (USD/Doses)
Table 61. Global Hepatitis B Vaccines Price by Application (2021-2026) & (USD/Doses)
Table 62. North America Hepatitis B Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 63. North America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses)
Table 64. North America Hepatitis B Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Hepatitis B Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 67. North America Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 68. North America Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 69. North America Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 70. Europe Hepatitis B Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 71. Europe Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses)
Table 72. Europe Hepatitis B Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Hepatitis B Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 75. Europe Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 76. Europe Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 77. Europe Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 78. Asia-Pacific Hepatitis B Vaccines Sales by Region (2016-2021e) & (M Doses)
Table 79. Asia-Pacific Hepatitis B Vaccines Sales by Region (2021-2026) & (M Doses)
Table 80. Asia-Pacific Hepatitis B Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Hepatitis B Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 83. Asia-Pacific Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 84. Asia-Pacific Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 85. Asia-Pacific Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 86. South America Hepatitis B Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 87. South America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses)
Table 88. South America Hepatitis B Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Hepatitis B Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 91. South America Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 92. South America Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 93. South America Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 94. Middle East & Africa Hepatitis B Vaccines Sales by Country (2016-2021e) & (M Doses)
Table 95. Middle East & Africa Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses)
Table 96. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Hepatitis B Vaccines Sales by Type (2016-2021e) & (M Doses)
Table 99. Middle East & Africa Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses)
Table 100. Middle East & Africa Hepatitis B Vaccines Sales by Application (2016-2021e) & (M Doses)
Table 101. Middle East & Africa Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Hepatitis B Vaccines Typical Distributors
Table 105. Hepatitis B Vaccines Typical Customers
List of Figures
Figure 1. Hepatitis B Vaccines Picture
Figure 2. Global Hepatitis B Vaccines Sales Market Share by Type in 2020
Figure 3. Yeast Derived
Figure 4. CHO Derived
Figure 5. Global Hepatitis B Vaccines Sales Market Share by Application in 2020
Figure 6. Children
Figure 7. Adult
Figure 8. Global Hepatitis B Vaccines Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 9. Global Hepatitis B Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Hepatitis B Vaccines Sales (2016-2026) & (M Doses)
Figure 11. Global Hepatitis B Vaccines Price by Type (2016-2026) & (USD/Doses)
Figure 12. Global Hepatitis B Vaccines Production Capacity (2016-2026) & (M Doses)
Figure 13. Global Hepatitis B Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Hepatitis B Vaccines Market Drivers
Figure 15. Hepatitis B Vaccines Market Restraints
Figure 16. Hepatitis B Vaccines Market Trends
Figure 17. Global Hepatitis B Vaccines Sales Market Share by Manufacturer in 2020
Figure 18. Global Hepatitis B Vaccines Revenue Market Share by Manufacturer in 2020
Figure 19. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Hepatitis B Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Hepatitis B Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2026)
Figure 23. Global Hepatitis B Vaccines Revenue Market Share by Region (2016-2026)
Figure 24. North America Hepatitis B Vaccines Revenue (2016-2026) & (USD Million)
Figure 25. Europe Hepatitis B Vaccines Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Hepatitis B Vaccines Revenue (2016-2026) & (USD Million)
Figure 27. South America Hepatitis B Vaccines Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Hepatitis B Vaccines Revenue (2016-2026) & (USD Million)
Figure 29. Global Hepatitis B Vaccines Sales Market Share by Type (2016-2026)
Figure 30. Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2026)
Figure 31. Global Hepatitis B Vaccines Price by Type (2016-2026) & (USD/Doses)
Figure 32. Global Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 33. Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2026)
Figure 34. Global Hepatitis B Vaccines Price by Application (2016-2026) & (USD/Doses)
Figure 35. North America Hepatitis B Vaccines Sales Market Share by Type (2016-2026)
Figure 36. North America Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 37. North America Hepatitis B Vaccines Sales Market Share by Country (2016-2026)
Figure 38. North America Hepatitis B Vaccines Revenue Market Share by Country (2016-2026)
Figure 39. United States Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Hepatitis B Vaccines Sales Market Share by Type (2016-2026)
Figure 43. Europe Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 44. Europe Hepatitis B Vaccines Sales Market Share by Country (2016-2026)
Figure 45. Europe Hepatitis B Vaccines Revenue Market Share by Country (2016-2026)
Figure 46. Germany Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Hepatitis B Vaccines Revenue Market Share by Region (2016-2026)
Figure 55. China Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Hepatitis B Vaccines Sales Market Share by Type (2016-2026)
Figure 62. South America Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 63. South America Hepatitis B Vaccines Sales Market Share by Country (2016-2026)
Figure 64. South America Hepatitis B Vaccines Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Hepatitis B Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---